Vitamin K cream reduces reactions at the injection site in patients with relapsing-remitting multiple sclerosis treated with subcutaneous interferon beta - VIKING study

Mult Scler. 2015 Aug;21(9):1215-6. doi: 10.1177/1352458514562989. Epub 2015 Feb 6.

Authors

Roberta Lanzillo¹, Marcello Moccia², Antonio Carotenuto², Veria Vacchiano², Barbara Satelliti², Valentina Panetta³, Vincenzo Brescia Morra²

Affiliations

¹ Multiple Sclerosis Centre, Federico II University, Italy [email protected] [email protected].
² Multiple Sclerosis Centre, Federico II University, Italy.
³ L'altrastatistica srl, Rome, Italy.

PMID: 25662354
DOI: 10.1177/1352458514562989

No abstract available

Publication types

Clinical Trial
Letter

MeSH terms

Cross-Over Studies
Humans
Immunologic Factors / administration & dosage
Immunologic Factors / adverse effects*
Injections, Subcutaneous / adverse effects
Interferon-beta / administration & dosage
Interferon-beta / adverse effects*
Multiple Sclerosis, Relapsing-Remitting / drug therapy*
Pain Measurement
Skin Cream / therapeutic use
Vitamin K / administration & dosage*

Substances

Immunologic Factors
Vitamin K
Interferon-beta